Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
FTXHvsIHFETF Comparison
First Trust Nasdaq Pharmaceuticals ETF (FTXH) and iShares U.S. Healthcare Providers ETF (IHF) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. FTXH is more expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.38% for IHF. FTXH is up 5.06% year-to-date (YTD) with +$7M in YTD flows. IHF performs worse with -8% YTD performance, and +$19M in YTD flows. Run a side-by-side ETF comparison of FTXH and IHF below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
FTXH vs IHF performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FTXH IHF | -0.60%-1.01% | +7.47%-7.69% | +5.06%-8.00% | +22.29%-13.05% | +43.33%-6.81% | +43.47%-5.29% |
| Flows | FTXH IHF | +$5M-$7M | +$9M+$9M | +$7M+$19M | +$10M+$94M | -$13M-$521M | +$4M-$353M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FTXH IHF | +15.29%+25.76% | +20.64%+24.10% | +15.87%+19.04% | +15.67%+18.82% |
| Max drawdown | FTXH IHF | -4.33%-12.35% | -17.49%-25.18% | -19.32%-29.86% | -19.32%-29.86% |
| Max drawdown duration | FTXH IHF | 9d63d | 203d331d | 393d553d | 393d553d |
FTXH | IHF | |
Last sale 3/11/2026 at 1:30 PM | $34.46 | $44.15 |
| Previous close 03/10/2026 | $34.57 | $44.13 |
| Consolidated volume 03/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
FTXH | IHF | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
FTXH | IHF | |
|---|---|---|
| Last price | $34.46 | $44.15 |
| 1D performance | -0.33% | +0.05% |
| AuM | $29.41 M | $699.21 M |
| E/R | 0.6% | 0.38% |
FTXH | IHF | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | First Trust | iShares |
| Benchmark | NASDAQ US Smart Pharmaceuticals Index | Dow Jones U.S. Select Health Care Providers Index |
| N° of holdings | 49 | 54 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 20, 2016 | May 1, 2006 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the FTXH and IHF ETFs performed in 2026?
As of March 10, 2026, FTXH is up 5.06% year-to-date (YTD), while IHF has lost -8%. That puts FTXH better performer ahead so far this year.
Which ETF is attracting more investor money: FTXH or IHF?
Year-to-date, the FTXH ETF saw +$7M in flows, compared to +$19M for IHF.
Which ETF is more volatile: FTXH or IHF?
Over the past year, FTXH had a volatility of 20.64%, while IHF experienced 24.1%.
Which ETF is bigger: FTXH or IHF?
As of March 10, 2026, FTXH holds $29.41 M in assets under management (AUM), while IHF manages $699.21 M.
What sectors do the FTXH and IHF ETFs invest in?
FTXH leans toward sectors like Health Care. Meanwhile, IHF focuses on Health Care.
What are the top holdings of the FTXH ETF and IHF ETF?
FTXH top holdings include MERCK & CO INC, JOHNSON&JOHNSON and BRISTOL-MYERS SQUIBB. IHF holds in its top three: UNITEDHEALTH GRP, CVS HEALTH CORP and ELEVANCE HEALTH INC.
Which ETF is more diversified: FTXH or IHF?
FTXH holds 50 securities with 71.63% of its assets in the top 15. IHF has 63 securities and a top 15 weight of 82.41%.
Healthcare Stocks Drop on Medicare Payment Rate Surprise
Investing in the Aging Demographics Megatrend
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
